Xiaoan Liu

3.2k total citations
121 papers, 2.3k citations indexed

About

Xiaoan Liu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Xiaoan Liu has authored 121 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 42 papers in Cancer Research and 35 papers in Molecular Biology. Recurrent topics in Xiaoan Liu's work include Breast Cancer Treatment Studies (23 papers), Cancer Cells and Metastasis (16 papers) and Breast Lesions and Carcinomas (14 papers). Xiaoan Liu is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Cancer Cells and Metastasis (16 papers) and Breast Lesions and Carcinomas (14 papers). Xiaoan Liu collaborates with scholars based in China, United States and Germany. Xiaoan Liu's co-authors include Wenbin Zhou, Qiang Ding, Shui Wang, Xiaoming Zha, Lijun Ling, Shui Wang, Tiansong Xia, Hong Pan, Yi Qian and Hua Chen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xiaoan Liu

114 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoan Liu China 29 786 728 708 344 244 121 2.3k
Weiguo Chen China 28 734 0.9× 604 0.8× 792 1.1× 252 0.7× 436 1.8× 168 2.3k
Xiru Li China 25 561 0.7× 371 0.5× 895 1.3× 201 0.6× 239 1.0× 102 2.0k
Zhi Yang China 30 891 1.1× 832 1.1× 1.6k 2.3× 220 0.6× 154 0.6× 113 3.0k
Wei He China 27 797 1.0× 558 0.8× 1.3k 1.9× 178 0.5× 157 0.6× 134 2.9k
Mohammad Vasei Iran 27 616 0.8× 462 0.6× 1.2k 1.6× 167 0.5× 122 0.5× 128 3.3k
Nikolaos Kavantzas Greece 30 371 0.5× 605 0.8× 1.0k 1.4× 240 0.7× 209 0.9× 183 2.9k
Chih‐Jung Chen Taiwan 26 554 0.7× 527 0.7× 748 1.1× 356 1.0× 123 0.5× 113 2.0k
Charalambos Solomides United States 33 598 0.8× 1.0k 1.4× 1.1k 1.6× 287 0.8× 273 1.1× 89 3.2k
Xin Du China 29 430 0.5× 518 0.7× 1.4k 1.9× 160 0.5× 138 0.6× 227 3.3k
Ren‐Chin Wu Taiwan 33 638 0.8× 742 1.0× 1.3k 1.8× 493 1.4× 117 0.5× 177 3.4k

Countries citing papers authored by Xiaoan Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaoan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoan Liu more than expected).

Fields of papers citing papers by Xiaoan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoan Liu. The network helps show where Xiaoan Liu may publish in the future.

Co-authorship network of co-authors of Xiaoan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoan Liu. A scholar is included among the top collaborators of Xiaoan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoan Liu. Xiaoan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoqiang, et al.. (2025). Melatonin-mediated cGAS-STING signal in senescent macrophages promote TNBC chemotherapy resistance and drive the SASP. Journal of Biological Chemistry. 301(5). 108438–108438. 4 indexed citations
2.
Gao, Yingchun, Xinghai Liu, Xinghai Liu, et al.. (2025). Integrating single-cell RNA-seq and bulk RNA-seq to explore prognostic value and immune landscapes of methionine metabolism-related signature in breast cancer. Frontiers in Genetics. 15. 1521269–1521269. 3 indexed citations
4.
Mao, Yuan, et al.. (2024). Suppression of AGRN enhances CD8 + T cell recruitment and inhibits breast cancer progression. The FASEB Journal. 38(7). e23582–e23582. 2 indexed citations
5.
Zhang, Manqi, Xinpei Liu, Yu Du, et al.. (2023). Prediction of pathological complete response of breast cancer patients who received neoadjuvant chemotherapy with a nomogram based on clinicopathologic variables, ultrasound, and MRI. British Journal of Radiology. 97(1153). 228–236. 1 indexed citations
6.
Du, Yu, Baoding Chen, Manqi Zhang, et al.. (2023). Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study. European Radiology. 34(1). 136–148. 19 indexed citations
7.
Shi, Xiaoyue, Hao Ding, Yanhui Zhu, et al.. (2023). Comprehensive evaluation of cell death-related genes as novel diagnostic biomarkers for breast cancer. Heliyon. 9(11). e21341–e21341. 3 indexed citations
8.
Zhu, Wenyong, Hao Huang, Rongxin Zhang, et al.. (2023). Delineating highly transcribed noncoding elements landscape in breast cancer. Computational and Structural Biotechnology Journal. 21. 4432–4445. 2 indexed citations
9.
Wang, Jiaming, Yue Sun, Xinrui Mao, et al.. (2023). Immune cells within tertiary lymphoid structures are associated with progression‐free survival in patients with locoregional recurrent breast cancer. Cancer Medicine. 13(1). e6864–e6864. 4 indexed citations
10.
Kong, Xiangdong, Languang Lu, Yuebo Yuan, et al.. (2022). Foreign matter defect battery and sudden spontaneous combustion. eTransportation. 12. 100170–100170. 63 indexed citations
12.
Li, Fu‐Yu, Yanhui Zhu, Yunfei Bai, et al.. (2022). Predicting hormone receptors and PAM50 subtypes of breast cancer from multi-scale lesion images of DCE-MRI with transfer learning technique. Computers in Biology and Medicine. 150. 106147–106147. 11 indexed citations
13.
14.
Pan, Hong, Mengjia Qian, Wenbin Zhou, et al.. (2019). Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience. Translational Cancer Research. 8(2). 389–401. 5 indexed citations
15.
Jia, Shanshan, et al.. (2017). Patent Classification Based on Multi-feature and Multi-classifier Integration. Shuju fenxi yu zhishi faxian. 1(8). 76–84. 1 indexed citations
16.
Xia, Tiansong, et al.. (2014). Infiltrating CD8 + T cells and regulatory T cells in breast cancer microenvironment. Zhonghua shiyan waike zazhi. 31(1). 149–151. 1 indexed citations
17.
Wu, Jian, et al.. (2013). [Expression of vascular endothelial growth factor receptor 3 in human breast cancer and its significance].. PubMed. 27(12). 1487–91. 1 indexed citations
18.
Zhou, Wenbin, Pengling Zhang, Xiaoan Liu, Tao Yang, & Wei He. (2011). Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis. Journal of Experimental & Clinical Cancer Research. 30(1). 72–72. 5 indexed citations
19.
Ling, Lijun, Shui Wang, Xiaoan Liu, et al.. (2008). A novel mouse model of human breast cancer stem-like cells with high CD44+CD24~/lower phenotype metastasis to human bone. Chinese Medical Journal. 121(20). 1980–1986. 30 indexed citations
20.
Liu, Xiaoan. (2006). A Method for Annual Maximum Runoff Forecast Based on Wavelet Analysis. China Rural Water and Hydropower. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026